More Benefits

How It Helps Your Patients

Evaluation of current health situation symptoms, medications and therapy reactions; Assessment of possible adequacy of the recovery process;

Initiation of Physician's focus to treat the onset of chronic situations or severity of the diseases; Evaluation of the prognosis and treatment outcomes;

Identification of abnormalities in cardiovascular, cerebrovascular system and overall health assessment;

Blood circulatory status — age of blood vessels based on arterial elasticity, peripheral circulatory status, organic/functional abnormality of the blood vessels;

Prediction and progression of Arteriosclerosis,

Obesity, Hypertension, Hyperlipidemia and Diabetes;

Useful as a health barometer.

How It Helps You

Monitoring current health of the individual patient closely;

Verifying the efficacy of current treatment protocol and intervention;

Examining patients for CAN and DAN — Cardiac

Autonomic Neuropathy and Diabetes

Autonomic Neuropathy;

Measuring the Metabolic Syndrome,

Hypertension, Heart Failure;

Predicting burn-out syndrome, anxiety, depression, psychological conditions; Exploring Asthma, COPD, Palpitations, Pain management, Sleep apnea PLUS; Optimization of treatment for each individual patient; Immediate reports — qualitative, quantitative and graphic analysis and results of ANS balance, cardiovascular, stress, fitness and overall health assessment for comparison with patient case history and necessary procedural actions

Efficient patient-centered multiple symptoms treatment management.

AUTONOMIC NERVOUS SYSTEM DYSFUNCTION RISK

Problems with the Cardio Metabolic can range from mild to life threatening. Sometimes only one part of the nervous system is affected. In other cases, the entire Cardio Metabolic system  is affected. Some conditions are temporary and can be reversed, while others are chronic and will continue to worsen over time. Diseases such as Diabetes or Parkinson's disease can cause irregularities with the ANS. Problems with Cardio Metabolic regulation often involve organ failure, or the failure of the nerves to transmit a necessary signal.

 ENDOTHELIAL DYSFUNCTION RISK

Current evidence suggests that endothelial function is an integrative marker of the net effects of damage from traditional and emerging risk factors on the arterial wall and its intrinsic capacity for repair. Endothelial dysfunction, detected as the presence of reduced vasodilating response to endothelial stimuli, has been observed to be associated with major cardiovascular risk factors, such as aging, hyperhomocysteinemia, post menopause state, smoking, diabetes, hyoercholesterolemia. and hvoertension.

SUDOMOTOR DYSFUNCTION RISK INSULIN RESISTANCE RISK

Sudomotor dysfunction testing may indicate to physicians of a patient's peripheral nerve and cardiac sympathetic dysfunction. Neuropathy is a common complication in diabetes mellitus (DM), with 60%—70% of patients affected over lifetime. Symptoms of neuropathy are very common, and subclinical neuropathy is more common than clinical neuropathy. Neuropathy may remain undetected, and progress over time leading to serious complications. The most common associated clinical condition is peripheral neuropathy, affecting the feet. Autonomic nerve involvement is common but probably the most undiagnosed. Low scores in the sudomotor may lead a medical provider to look at clinical neuropathy.

SUDOMOTOR DYSFUNCTION RISK INSULIN RESISTANCE RISK

The PTG CVD risk factor is the combined total of the other seven risk factors assessments. It takes into consideration the cardiovascular, as well as, the autonomic nervous system (ANS) measurements.

SMALL FIBER NEUROPATHY RISK

A small fiber neuropathy occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated fibers or Unmyelinated C fibers. The specific fiber types involved in this process include both small somatic and autonomic fibers. The sensory functions of these fibers include thermal perception and nociception. These fibers are involved in many autonomic and enteric function.

INSULIN RESISTANCE RISK

Insulin resistance is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population. Insulin resistance occurs as part of a cluster of cardiovascular- metabolic abnormalities commonly referred to as "The Insulin

Resistance Syndrome" or "The Metabolic Syndrome". This cluster of abnormalities may lead to the development of type 2 diabetes, accelerated atherosclerosis, hypertension or polycystic ovarian syndrome depending on the genetic background of the individual developing the insulin

CARDIOMETABOLIC RISK CARDIAC AUTONOMIC NEUROPATHY RISK

The specific factors that can cause this increased risk include: obesity (particularly central), hyperglycemia, hypertension, insulin resistance and dyslipoproteinemia. When patients have one or more risk factors and are physically inactive or smoke, the cardiometabolic risk is increased even more. Medical conditions that often share the above characteristics, such as type 2 diabetes, can also increase cardiometabolic risk. The primary focus of cardiometabolic risk treatment is management of each high-risk factor, including dyslipoproteinemia, hypertension, and diabetes. The management of these subjects is based principally on lifestyle measures, but various antihypertensive, lipid-lowering, insulin sensitizing, anti-obesity and antiplatelet drugs could be helDful in reducing cardiometabolic risk.

CARDIAC AUTONOMIC NEUROPATHY RISK

High blood glucose levels over a period of years may cause a condition called autonomic neuropathy. This is damage to the nerves that control the regulation of involuntary function. When the nerve damage affects the heart, it is called cardiac autonomic neuropathy (CAN). CAN encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart rate control, vascular dynamics and the body's ability to adjust blood pressure. CAN is a significant cause of morbidity and mortality associated with a high risk of cardiac arrhythmias and sudden death.

Peripheral Small Fiber Neuropathy

Frequently associated with

Diabetes, Pre-Diabetes and Metabolic Syndrome.

Other conditions may include: HIV, GuillainBarre Syndrome, Celiac

Disease, Hepatitis C,

Restless Leg Syndrome, Abnormal Thyroid Function.

Cardiac Autonomic Neuropathy (CAN)

High blood glucose levels over a period of years may cause CAN. Nerves that signal the heart to beat faster are called Autonomic Nerves. When nerve damage affects the heart, it is referred to as CAN. CAN is not a disease of the heart; it is a problem with the nerves that control heart rate.

Early Detection for Endothelial Dysfunction

Endothelial dysfunction is a well-established response to cardiovascular risk factors and precedes the development of atherosclerosis. When cardiovascular risk factors are treated the endothelial dysfunction may be reversed.

It is an independent predictor of cardiac events.

Cardiovascular and Peripheral Artery Disease

Atherosclerosis is the most common cause of CVD. Plaque buildup thickens and stiffens artery walls which inhibit blood flow through arteries to organs and tissues. In the heart it is known as coronary artery disease and in the legs it is known as peripheral arterial disease (PAD). CVD and PAD can be caused by correctable problems, such as an unhealthy diet, lack of exercise, being overweight and smoking.

Cardio-Metabolic Risk Markers (CMR) 

Cardio Metabolic testing provides important Cardio metabolic Risk Measurements (CMR):

a set of results used to assess the cluster of risk factors which are good indicators of a patient's overall risk for type 2 diabetes and cardiovascular disease (CVD). CMR focuses clinical attention on the value of systematic evaluation, education, lifestyle and behavior changes, disease prevention, and treatment. Assessing CMR provides a more comprehensive picture of a patient's health and potential risk for future disease.

Adjunct in Diabetes Treatment

Adjunct in Diabetes Treatment Early detection of Peripheral Small Fiber Neuropathy and

Cardiac Autonomic Neuropathy. Testing the autonomic nervous system can identify clinical autonomic disorders, uncover major illness and other hidden diseases, such as: Sudden Death, Heart Attack, Hypertension, Cardiac, Autonomic Neuropathy, Vascular Abnormalities, Orthostatic Hypotension, Syncop